1. How many multiple sclerosis patients have been treated with these drugs in the past 6 months?
Ampyra (fampyra)
Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Brabio (glatiramer acetate)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Mavenclad (cladribine)
Mayzent (siponimod)
Ocrevus (ocrelizumab)
Plegridy (peginterferon beta-1a)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Vumerity (diroximel fumarate)
Zeposia (ozanimod)
Zinbryta (daclizumab)
2. How many MS patients have been diagnosed with relapsing (RRMS), primary progressive (PPMS) or secondary progressive (SPMS) MS?
RRMS
PPMS
SPMS
Not known